Canopy Growth Corporation v. GW Pharma Limited
CANOPY GROWTH CORPORATION |
GW PHARMACEUTICALS PLC, GW PHARMA LIMITED and GW RESEARCH LIMITED |
22-1603 |
April 7, 2022 |
U.S. Court of Appeals, Federal Circuit |
Patent Infringement (Fed. Qst.) |
Opinions
We have the following opinions for this case:
Description |
---|
CANOPY GROWTH CORPORATION v. GW PHARMA LIMITED |
Docket Report
This docket was last retrieved on May 19, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 19 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 18 ] filed by Appellant Canopy Growth Corporation. The opening brief is due 06/21/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [850746] [ALK] [Entered: 05/19/2022 02:19 PM] |
Filing 18 MOTION of Appellant Canopy Growth Corporation to extend the time to 06/21/2022 to file brief. Service: 05/18/2022 by email. [850569] [22-1603] [Kurt Pankratz] [Entered: 05/18/2022 06:35 PM] |
Filing 17 ORDER granting motion to modify the official caption [ # 13 ] filed by Appellees. The revised official caption and the revised short caption are reflected above. Service as of this date by the Clerk of Court. [847510] [LMS] [Entered: 05/04/2022 12:48 PM] |
Filing 16 Corrected Entry of appearance for Gerald J. Flattmann, Jr.; Steven M. Zager; Evan D. Diamond; Vanessa Y. Yen as counsel for Appellees GW Pharma Limited and GW Research Limited. Service: 05/03/2022 by email. [847265] [22-1603] [Gerald Flattmann] [Entered: 05/03/2022 03:52 PM] |
Filing 15 NOTICE OF NON-COMPLIANCE: The submission of Appellees GW Pharma Limited and GW Research Limited, Entry of Appearance [ # 11 ], is not in compliance with the rules of this court (see attached). Compliant document due on 05/10/2022. Service as of this date by the Clerk of Court. [847131] [ALK] [Entered: 05/03/2022 12:06 PM] |
Filing 14 Corrected Docketing Statement for the Appellees GW Pharma Limited and GW Research Limited. Service: 05/02/2022 by email. [846986] [22-1603] [Gerald Flattmann] [Entered: 05/02/2022 06:53 PM] |
Filing 13 MOTION of Appellees GW Pharma Limited and GW Research Limited to modify the official caption. Service: 04/28/2022 by email. [846147] [22-1603] [Gerald Flattmann] [Entered: 04/28/2022 05:44 PM] |
Filing 12 Corrected Certificate of Interest for Appellees GW Pharma Limited and GW Research Limited. Service: 04/28/2022 by email. [846146] [22-1603] [Gerald Flattmann] [Entered: 04/28/2022 05:41 PM] |
Filing 11 Corrected Entry of appearance for Gerald J. Flattmann, Jr.; Steven M. Zager; Evan D. Diamond; Vanessa Y. Yen as counsel for Appellees GW Pharma Limited and GW Research Limited. Service: 04/28/2022 by email. [846145] [22-1603] This document is non-compliant. See Doc No. [ # 15 ]. [Gerald Flattmann] [Entered: 04/28/2022 05:39 PM] |
Filing 10 NOTICE OF NON-COMPLIANCE: The submissions of Appellees GW Pharma Limited, GW Pharmaceuticals PLC and GW Research Limited, Entry of Appearance [ # 6 ], Certificate of Interest [ # 7 ], and Docketing Statement [ # 8 ], are not in compliance with the rules of this court (see attached). Compliant documents due on 05/02/2022. Service as of this date by the Clerk of Court. [845145] [ALK] [Entered: 04/25/2022 11:08 AM] |
Filing 9 Entry of appearance for Melissa Muenks as counsel for Appellant Canopy Growth Corporation. Service: 04/22/2022 by email. [845064] [22-1603] [Melissa Muenks] [Entered: 04/22/2022 07:18 PM] |
Filing 8 Docketing Statement for the Appellees GW Pharma Limited, GW Pharmaceuticals PLC and GW Research Limited. Service: 04/21/2022 by email. [844716] [22-1603] This document is non-compliant. See Doc No. [ # 10 ]. [Gerald Flattmann] [Entered: 04/21/2022 04:26 PM] |
Filing 7 Certificate of Interest for Appellees GW Pharma Limited, GW Pharmaceuticals PLC and GW Research Limited. Service: 04/21/2022 by email. [844712] [22-1603] This document is non-compliant. See Doc No. [ # 10 ]. [Gerald Flattmann] [Entered: 04/21/2022 04:25 PM] |
Filing 6 Entry of appearance for Gerald J. Flattmann, Jr.; Steven M. Zager; Evan D. Diamond; Vanessa Y. Yen as counsel for Appellees GW Pharma Limited, GW Pharmaceuticals PLC and GW Research Limited. Service: 04/21/2022 by email. [844708] [22-1603] This document is non-compliant. See Doc No. [ # 10 ]. [Gerald Flattmann] [Entered: 04/21/2022 04:22 PM] |
Filing 5 NOTICE OF NON-COMPLIANCE: The submission of Appellant Canopy Growth Corporation, Entry of Appearance [ # 2 ], is not in compliance with the rules of this court (see attached). Compliant document due on 04/27/2022. Service as of this date by the Clerk of Court. [844290] [ALK] [Entered: 04/20/2022 12:02 PM] |
Filing 4 Docketing Statement for the Appellant Canopy Growth Corporation. Service: 04/19/2022 by email. [844197] [22-1603] [Kurt Pankratz] [Entered: 04/19/2022 07:32 PM] |
Filing 3 Certificate of Interest for Appellant Canopy Growth Corporation. Service: 04/19/2022 by email. [844195] [22-1603] [Kurt Pankratz] [Entered: 04/19/2022 07:30 PM] |
Filing 2 Entry of appearance for Kurt Pankratz; Clarke Stavinoha; Melissa Muenks; David Wille; Michael Hawes as counsel for Appellant Canopy Growth Corporation. Service: 04/19/2022 by email. [844194] [22-1603]. This document is non-compliant. See Doc No. [ # 5 ]. --[Edited 04/25/2022 by ALK. Deficiency corrected ; see [ # 9 ].] [Kurt Pankratz] [Entered: 04/19/2022 07:26 PM] |
Filing 1 Appeal docketed. Received: 04/05/2022. [841741] Entry of Appearance is due on 04/21/2022. Certificate of Interest is due on 04/21/2022. Docketing Statement is due on 04/21/2022. Appellant's brief is due on 06/06/2022. [ALK] [Entered: 04/07/2022 03:20 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.